These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31754650)
1. A common mechanism allows selective targeting of GluN2B subunit-containing Schreiber JA; Schepmann D; Frehland B; Thum S; Datunashvili M; Budde T; Hollmann M; Strutz-Seebohm N; Wünsch B; Seebohm G Commun Biol; 2019; 2():420. PubMed ID: 31754650 [No Abstract] [Full Text] [Related]
2. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold. Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308 [TBL] [Abstract][Full Text] [Related]
3. Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity. Rath S; Schepmann D; Wünsch B Bioorg Med Chem; 2017 Oct; 25(20):5365-5372. PubMed ID: 28797770 [TBL] [Abstract][Full Text] [Related]
4. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists. Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815 [TBL] [Abstract][Full Text] [Related]
8. 2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists. Dey S; Schepmann D; Wünsch B Bioorg Med Chem; 2018 Jan; 26(2):501-508. PubMed ID: 29254894 [TBL] [Abstract][Full Text] [Related]
9. Replacement of the Benzylpiperidine Moiety with Fluorinated Phenylalkyl Side Chains for the Development of GluN2B Receptor Ligands. Thum S; Schepmann D; Kalinin DV; Ametamey SM; Wünsch B ChemMedChem; 2018 Dec; 13(23):2522-2529. PubMed ID: 30312542 [TBL] [Abstract][Full Text] [Related]
10. Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists. Wagner M; Schepmann D; Ametamey SM; Wünsch B Bioorg Med Chem; 2019 Aug; 27(16):3559-3567. PubMed ID: 31255496 [TBL] [Abstract][Full Text] [Related]
11. Exploring the overlapping binding sites of ifenprodil and EVT-101 in GluN2B-containing NMDA receptors using novel chicken embryo forebrain cultures and molecular modeling. Fjelldal MF; Freyd T; Evenseth LM; Sylte I; Ring A; Paulsen RE Pharmacol Res Perspect; 2019 Jun; 7(3):e00480. PubMed ID: 31164987 [TBL] [Abstract][Full Text] [Related]
13. Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold. Dey S; Schepmann D; Wünsch B Bioorg Med Chem Lett; 2016 Feb; 26(3):889-893. PubMed ID: 26750254 [TBL] [Abstract][Full Text] [Related]
14. Fluorinated GluN2B Receptor Antagonists with a 3-Benzazepine Scaffold Designed for PET Studies. Szermerski M; Börgel F; Schepmann D; Haider A; Betzel T; Ametamey SM; Wünsch B ChemMedChem; 2018 May; 13(10):1058-1068. PubMed ID: 29522653 [TBL] [Abstract][Full Text] [Related]
15. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453 [TBL] [Abstract][Full Text] [Related]
16. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063 [TBL] [Abstract][Full Text] [Related]
17. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study. Kumar G; Patnaik R Med Hypotheses; 2016 Jul; 92():35-43. PubMed ID: 27241252 [TBL] [Abstract][Full Text] [Related]
19. Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug. Mazumder MK; Borah A Med Hypotheses; 2014 Dec; 83(6):740-6. PubMed ID: 25459147 [TBL] [Abstract][Full Text] [Related]
20. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit. Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]